Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Applied Therapeutics, Inc. (APLT)

Core Points - A securities class action lawsuit has been filed against Applied Therapeutics, Inc. for the period between January 3, 2024, and December 2, 2024 [1] - The lawsuit follows the FDA's issuance of a Complete Response Letter for the NDA of govorestat, indicating deficiencies in the clinical application, which led to a stock price drop of over 80% [2] - Following a warning from the FDA regarding issues with electronic data capture and a dosing error, the stock price fell more than 26% [3] Company Summary - The lawsuit is on behalf of all individuals or entities that purchased Applied Therapeutics securities during the specified class period [1] - The FDA's Complete Response Letter was issued on November 27, 2024, which significantly impacted the company's stock value [2] - The subsequent FDA warning on December 2, 2024, further exacerbated the decline in stock price [3] Legal Context - Investors are encouraged to contact the law firm Gainey McKenna & Egleston before the lead plaintiff motion deadline of February 18, 2025 [4]